At an extremely high plasma amylin concentration, probably in nanomole-per-liter ranges, for a long duration, there may be an independent pathway for AD pathogenesis stemming from amylin’s physiological effects as a hormone. The gene discussed is IAPP; the disease is Alzheimer disease.